Birmingham researchers to make MGUS monitoring more efficient Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people with MGUS ...

Population attributable fractions for risk factors for the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in the Veteran population.. If you have the appropriate ...

Analyzing the impact of type 1 and type 2 diabetes on patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM): A retrospective study at a tertiary care center ...

Monoclonal gammopathy of undetermined significance (MGUS) was found to have no association with autoimmune disorders.

In a systematically screened population, there is no association between autoimmune disease and monoclonal gammopathy of undetermined significance (MGUS), according to a study published online May ...

Contrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise risk for autoimmune disease when examined in ...

MGUS (monoclonal gammopathy of undetermined significance) causes the body to create M protein. It isn't usually cause for concern unless it progresses.

The global monoclonal gammopathy of undetermined significance (MGUS) management market is expected to garner a market value of US$ 27 million in 2023 and is expected to accumulate a market value of ...

ROACH: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show this blood ...

Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 ...